Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

American Heart Journal

Volumn 139, Issue 2 III, 2000, Pages

  Colonna, P ^a   Iliceto, S ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DOUBLE BLIND PROCEDURE; FEMALE; HEART DILATATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE SIZE; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033981684     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.103918     Document Type: Conference Paper

References (28)

1. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
2. St John Sutton M, Pfeffer MA, Plappert T, Rouleau J-L, Moyé LA, Dagenais GR, et al for the SAVE Investigators. Quantitative twodimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89:68-75.
3. Ferrari R, Cucchini F, Di Lisa F, et al. The effect of L-carnitine on myocardial metabolism of patients with coronary artery disease. Clin Trials J 1984;21:40-58.
4. Spangoli LG, Corsi M, Villaschi S, Palmieri G, Maccari F. Myocardial carnitine deficiency in acute myocardial infarction. Lancet 1982;1:1419-20.
5. Regitz V, Shug AL, Fleck E. Defective myocardial metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. Am J Cardiol 1990;65:755-60.
6. Fujiwara M, Nakano T, Tamoto S, Yamada Y, Fukai M, Ashida H, et al. Effect of L-carnitine in patients with ischemic heart disease. Am J Cardiol 1991;21:493-504.
7. Thomsen JH, Shug AL, Yap VU, Patel AK, Karras TJ, DeFelice SL. Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol 1979;43:300-6.
8. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, et al for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after acute myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.
9. GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:115-22.
10. AIRE study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
11. Lowe JE, Reimer KA, Jennings RB. Experimental infarct size as a function of the amount of myocardium at risk. Am J Pathol 1978; 90:363-80.
12. Bruce CJ, Christian TF, Schaer GL, Spaccavento LJ, Jolly MK, O'Connor MK, et al. Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol 1999; 83:1600-5.
13. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure, and myocardial damage. Circulation 1983;68(Suppl I):8-15.
14. Wilcox RG. Late assessment of thrombolytic efficacy: randomized trial of alteplase or placebo 6-24 hours after symptoms of acute myocardial infarction [abstract]. Eur Heart J 1992;13:423.
15. Leung WH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 1992; 20:307-13.
16. Bolognese L, Cerisano G, Buonamici P, Santini A, Santoro GM, Antoniucci D, et al. Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. Circulation 1997;96:3353-9.
17. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the "no reflow" phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
18. Iliceto S, Galiuto L, Marchese A, Cavallari D, Colonna P, Biasco G, et al. Analysis of microvascular integrity, contractile reserve and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996;77:441-4.
19. Galiuto L, DeMaria A, del Balzo U, May Newman K, Kirchengast M, Flaim S, et al. Endothelin α-antagonist reduces no-reflow and infarct size in dogs. J Am Coll Cardiol 1999;33(Suppl A):382A.
20. Taniyama Y, Ito H, Iwakura K, Masuyama T, Hori M, Takiuchi S, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with myocardial infarction. J Am Coll Cardiol 1997;30:1193-9.
21. Opie LH. Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 1979;97:375-88.
22. Shug AL, Thomsen JH, Folts JD, Bitter N, Klein MI, Koke JR, et al. Changes in tissue levels of carnitine and other metabolites during ischaemia and anoxia. Arch Biochem Biophys 1978; 187:25-33.
23. Rizzon P, Biasco G, Boscia F, Rizzo U, Minafra F, Bortone A, et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J 1989;10:502-8.
24. Liedtke AJ, DeMaison L, Nellis SH. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988;255:H169-76.
25. Micheletti R, Giacalone G, Canepari M, Salardi S, Bianchi G, Reggiani C. Propionyl-L-carnitine prevents myocardial mechanical alterations due to pressure overload in rats. Am J Physiol 1994; 266:H2190-7.
26. Iliceto S, Galiuto L, Marchese A, Cavallari D, Colonna P, Biasco G, et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996;77:441-5.
27. Iliceto S, D'Ambrosio G, Scrutinio D, Marangelli V, Boni L, Rizzon P. A digital network for long-distance echocardiographic image and data transmission in clinical trials: the CEDIM study experience. J Am Soc Echocardiogr 1993;6:583-92.
28. Bonarjee VV, Carstensen S, Caidahl K, Nilsen DW, Edner M, Berning J. Attenuation of left ventricular dilatation after acute myocardial infarction by early initiation of enalapril therapy. CONSENSUS II Multi-Echo Study Group. Am J Cardiol 1993;72:1004-9.